Tennessee Valley Asset Management Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-40
Closed -$7.66K 147
2023
Q4
$7.66K Buy
+40
New +$7.66K ﹤0.01% 495